Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Pharmacokinetics and Metabolism of Radiolabeled BMS-690514 in Healthy Male Subjects (NCT00578916)Bristol-Myers Squibb2008-01-01
Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Diabetes Mellitus (NCT01868529)Novo Nordisk A/S2008-01-01
A Study to Evaluate the Effect of Testosterone on Muscle Fractional Synthetic Rate (MK-0000-064) (NCT00816712)Merck Sharp & Dohme LLC2008-01-01
ACY-7 Oral Administration of Acyline (NCT00603187)University of Washington2008-01-01
Study in Patients With Mild to Moderate Psoriasis (NCT01451346)Alimentary Health Ltd2008-01-01
Safety Study of GPX-150 in Patients With Solid Tumors (NCT00710125)Gem Pharmaceuticals2008-01-01
Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma (NCT00625768)Antisoma Research2008-01-01
Clinical Study on Oral Nemonoxacin Malate Capsules (NCT01395108)TaiGen Biotechnology Co., Ltd.2008-01-01
Study Evaluating Safety and Tolerability of Ascending Multiple Dose of SLV-313 in Schizophrenia Patients (NCT00581243)Wyeth is now a wholly owned subsidiary of Pfizer2008-01-01
A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Sodium ST20 in Healthy Volunteers (NCT00614016)HemaQuest Pharmaceuticals Inc.2008-01-01
Pilot Study Evaluating the Safety and Potential Trends in Efficacy of Adhexil (NCT00544310)OMRIX Biopharmaceuticals2008-01-01
Study to Investigate the Effects Single Oral Dose of AZD1386 (Capsaicin) (NCT00692146)AstraZeneca2008-01-01
Autologous Bone Marrow Stem Cells in Cirrhosis Patients (NCT00713934)Royan Institute2008-01-01
A Phase 1 Study of ARQ 197 in Patients With Solid Tumors (NCT00609921)Kyowa Kirin Co., Ltd.2008-01-01
Tolerability/Safety of Intranasal AZD8848 in Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season (NCT00688779)AstraZeneca2008-01-01
Treating Parastomal Hernia With a Mesh (NCT02233465)Norrbottens Lans Landsting2008-01-01
Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma (NCT00720135)City of Hope Medical Center2008-01-01
Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia (NCT00625729)Masonic Cancer Center, University of Minnesota2008-01-01
Efficacy and Tolerance of Naked DNA Vaccine in Patients With Chronic B Hepatitis (NCT00536627)French National Agency for Research on AIDS and Viral Hepatitis2008-01-01
A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects (NCT00621881)NicOx2008-01-01
Drug-Drug Interaction of Cladribine and Pantoprazole in Multiple Sclerosis Subjects (NCT00938366)Merck KGaA, Darmstadt, Germany2008-01-01
Extension Study of Intrathecal Enzyme Replacement Therapy for MPS I (NCT00786968)Patricia I. Dickson, M.D.2008-01-01
Investigate the Effect on the QT/QTc Interval of Repeated and Escalating Doses of AZD3480 During 6 Days (NCT00686179)AstraZeneca2008-01-01
Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia (NCT00612612)National Cancer Institute (NCI)2008-01-01
Safety of Cat-PAD in Cat Allergic Subjects (NCT00685711)Circassia Limited2008-01-01
Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lymphoma (NCT00614042)Aptevo Therapeutics2008-01-01
Single Ascending Dose Study (SAD) iv Formulation (NCT00688831)AstraZeneca2008-01-01
Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa (NCT00558844)Insmed Incorporated2008-01-01
A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis (NCT00631462)TargeGen2008-01-01
Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study (NCT00630786)Amgen2008-01-01
The Cyclocapnic Method for Measurement of Chemosensitivity (NCT01049256)Imperial College London2008-01-01
Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing Prostatectomy (NCT01009736)Ohio State University Comprehensive Cancer Center2008-01-01
Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer (NCT00603863)Gilead Sciences2008-01-01
A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma (NCT00659659)MedImmune LLC2008-01-01
Social Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical Trail (NCT00618280)Heinrich-Heine University, Duesseldorf2008-01-01
Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors (NCT00608803)Alaunos Therapeutics2008-01-01
Neurally Adjusted Ventilatory Assist (NAVA) in Patients With Critical Illness Associated Polyneuropathy / or Polymyopathy (CIP/M) (NCT00614562)Insel Gruppe AG, University Hospital Bern2008-01-01
Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05% (NCT00604032)Coria Laboratories, Ltd.2008-01-01
Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2066 in Young and Elderly Healthy Subjects (NCT00684502)AstraZeneca2008-01-01
A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMD (NCT00793923)Subhransu K. Ray, M.D., Ph.D.2008-01-01
Clinical Evaluation of the Photoallergy Potential of Atralin Gel (NCT00603772)Coria Laboratories, Ltd.2008-01-01
Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas (NCT00750386)Hellenic Oncology Research Group2008-01-01
Pounds Off Digitally Study: A Podcasting Weight Loss Intervention (NCT00771095)University of North Carolina, Chapel Hill2008-01-01
Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer (NCT00603538)Pfizer2008-01-01
Steady State Study of Codeine Sulfate (NCT01009853)Roxane Laboratories2008-01-01
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL (NCT00546793)Gilead Sciences2008-01-01
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (NCT01762046)Massachusetts General Hospital2008-01-01
Ability of Aprepitant to Block Opioid Reward in Non-Dependent Opiate Abusers (NCT00726960)Karolinska University Hospital2008-01-01
Comparative Bioavailability Study of Codeine Sulfate (NCT01010152)Roxane Laboratories2008-01-01
Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid (NCT00692705)AstraZeneca2008-01-01
Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer (NCT00707252)Louisiana State University Health Sciences Center Shreveport2008-01-01
A Pilot Study of PPX in Women With Metastatic Colorectal Cancer (NCT00598247)University of Southern California2008-01-01
Cotransplantation of Islet and Mesenchymal Stem Cell in Type 1 Diabetic Patients (NCT00646724)Fuzhou General Hospital2008-01-01
Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddy's Under Fasting Conditions (NCT01131988)Dr. Reddy's Laboratories Limited2008-01-01
Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III (NCT00439569)Westat2008-01-01
Vandetanib and Temozolomide in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery (NCT00601614)Mayo Clinic2008-01-01
Effectiveness of Cognitive Remediation Therapy in Improving Treatment Retention in People With Anorexia Nervosa (NCT00601822)Stanford University2008-01-01
COPE Intervention for Parents of Children With Epilepsy (NCT00767026)Boston Children's Hospital2008-01-01
Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric Junction (NCT01042782)Krankenhaus Nordwest2008-01-01
Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells (NCT00672542)Scott Pruitt2008-01-01
Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological Malignancies (NCT00595686)Esanex Inc.2008-01-01
Bioavailability of Soft Gelatin Capsule Formulation of BI 201335 NA Compared to the Solution Formulation in Healthy Volunteers (NCT02182284)Boehringer Ingelheim2008-01-01
Staccato Alprazolam Abuse Liability (NCT00603980)Nova Pneuma Inc.2008-01-01
Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-diagnosed Light-chain (AL)-Amyloidosis (NCT00621400)Nantes University Hospital2008-01-01
Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors (NCT00607399)SGX Pharmaceuticals, Inc.2008-01-01
Study Evaluating the Safety, Tolerability, and Pharmacokinetics (PK) of HKI-357 Administered Orally to Healthy Subjects (NCT00550381)Wyeth is now a wholly owned subsidiary of Pfizer2008-01-01
Study Evaluating the Safety and Tolerability of Single Ascending Dose (SAD) SLV-351 in Healthy Subjects (NCT00581191)Wyeth is now a wholly owned subsidiary of Pfizer2008-01-01
Effects of CS-8080 in Healthy Volunteers (NCT00613431)Daiichi Sankyo2008-01-01
Phase I Study of SB-480848(Darapladib) -Repeat Dose Study in Healthy Japanese Male Subjects- (NCT00622830)GlaxoSmithKline2008-01-01
PET Imaging of Cannabinoid CB1 Receptors Using [18F]FMPEP-d2 (NCT00598286)National Institute of Mental Health (NIMH)2008-01-01
Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors (NCT00879684)Pfizer2008-01-01
Food Effect Study of Codeine Sulfate (NCT01009892)Roxane Laboratories2008-01-01
Treatment of Acute Tracheitis and Laryngitis With Essential Oils of Aromatic Plants (NCT00611390)HaEmek Medical Center, Israel2008-01-01
A Safety, Tolerability and Pharmacodynamics Study of ACE-011 (ActRIIA-IgG1) in Healthy Postmenopausal Women (NCT00709540)Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2008-01-01
Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression (NCT00659399)NYU Langone Health2008-01-01
Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours (NCT00621725)AstraZeneca2008-01-01
Topical IL-1-Ra for Treatment of Posterior Blepharitis (NCT00681109)Reza Dana, MD2008-01-01
Safety Study of Polylactide-Caprolactone-Trimethylenecarbonate Copolymer for Post-Operative Adhesion Prophylaxis (NCT00597662)University Hospital Tuebingen2008-01-01
A Dose-Escalation Study in Participants With Advanced Cancer (NCT01524224)Eli Lilly and Company2008-01-01
Phase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin for the Treatment of Bilateral Idiopathic Parkinson's Disease (NCT00627588)Oxford BioMedica2008-01-01
Multiple Rising Inhalative Doses of BI 1744 CL in Healthy Male Volunteers (NCT02172105)Boehringer Ingelheim2008-01-01
Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes (NCT00971659)Profil Institut für Stoffwechselforschung GmbH2008-01-01
Treatment of Acute Rhino-Sinusitis With Essential Oils of Aromatic Plants (NCT00610779)HaEmek Medical Center, Israel2008-01-01
A Single Ascending Dose Study of BMS-650032 in HCV Infected Subjects (NCT00559247)Bristol-Myers Squibb2008-01-01
Immunotherapy Vaccine and Herceptin in Breast Cancer (NCT03014076)Cancer Insight, LLC2008-01-01
Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer (NCT00846612)NYU Langone Health2008-01-01
Evaluation of Four Reconstructions After Total Gastrectomy (NCT00677456)Tang-Du Hospital2008-01-01
Assessment of Physical Exercise Using Stationary Bicycle for Pregnant Women With Risk for Preeclampsia Development (NCT01395342)University of Campinas, Brazil2008-01-01
Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant (NCT00674427)University of Pennsylvania2008-01-01
Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors (NCT00684957)Columbia University2008-01-01
Breast Feeding Analgesia in Preterm Infants (NCT00175409)University of British Columbia2008-01-01
A Single Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers (NCT00606112)Genaera Corporation2008-01-01
Short Term Effects of Photodynamic Therapy in Basal Cell Carcinoma (NCT01015898)Shahid Beheshti University of Medical Sciences2008-01-01
A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers (NCT00619931)Arena Pharmaceuticals2008-01-01
A Gene by Medication Interaction to the Acute Effects of Alcohol (NCT01343628)University of Virginia2008-01-01
Autologous Transplantation of Bone Marrow Mononuclear Cell (BM-MNC) With and Without Granulocyte-Colony Stimulation Factor (G-CSF) for Treatment of Chronic Lower Limb Ischemic Patients (NCT00677404)Royan Institute2008-01-01
IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor (NCT00609141)National Cancer Institute (NCI)2008-01-01
Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses of BI 11054 CL Administered With the Respimat® in Healthy Male Volunteers (NCT02273401)Boehringer Ingelheim2008-01-01
Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma (NCT00882063)Piramal Enterprises Limited2008-01-01
Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy (NCT00593242)Michael Cotten2008-01-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.